Abraxis BioScience News
Most Popular Abraxis BioScience Story
Abraxis mulls sale of company
Abraxis Bioscience has retained Goldman Sachs and Lazard to explore the possible sale of the company, sources tell dealReporter. The rumored deal talks follow the release of data last month showing Read more...
Latest Headlines
- November 22, 2010
- April 14, 2010
- January 20, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
